Cargando…
Answer to Mungmunpuntipantip et al. “SARS CoV-2 vaccine AND rituximab” Joint Bone Spine 2021;88:105281
Autores principales: | Verhoeven, Frank, Lepiller, Quentin, Hecquet, Sophie, Prati, Clément, Wendling, Daniel |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Société française de rhumatologie. Published by Elsevier Masson SAS.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8483993/ https://www.ncbi.nlm.nih.gov/pubmed/34601112 http://dx.doi.org/10.1016/j.jbspin.2021.105283 |
Ejemplares similares
-
Answer to De Marchi et al. Joint Bone Spine 2022;89:105408
por: Verhoeven, Frank, et al.
Publicado: (2022) -
SARS CoV-2 vaccine AND rituximab, timing might be a key for a better vaccine response
por: Verhoeven, Frank, et al.
Publicado: (2021) -
Answer to Mungmunpuntipantip et al. Joint Bone Spine 2023;90:105518
por: Lombès, Amélie, et al.
Publicado: (2023) -
Answer to Cabona et al « Isolated musculocutaneous nerve involvement in COVID-19 related Neuralgic amyotrophy» Joint Bone Spine 2021;88:105238 and to Finsterer and Scorza « SARS-CoV-2 or SARS-CoV-2 vaccination associated Parsonage-Turner syndrome». Joint Bone Spine 2021;88:105239
por: Coll, Clemence, et al.
Publicado: (2021) -
Comment on: “SARS CoV-2 vaccine AND rituximab, timing is probably a key for a better vaccine response” by Verhoeven et al. Joint Bone Spine 2021;88:105258
por: De Marchi, Ginevra, et al.
Publicado: (2022)